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General 
 
All chemicals were purchased from commercial sources and used without further 
puriﬁcation unless otherwise noted. Tetrahydrofuran (THF) was distilled from potassium 
benzophenone ketyl under an argon atmosphere prior to use. Methylene Chloride 
(CH2Cl2), was distilled from calcium hydride under an Argon atmosphere. All stirring 
was performed with an internal magnetic stirrer. Reactions were monitored by thin-layer 
chromatography (TLC) performed with 0.25 mm coated commercial silica gel plates 
(EMD, Silica Gel 60F254) using UV light for visualization at 254 nm, or developed with 
ceric ammonium molybdate or anisaldehyde or copper sulfate or ninhydrin solutions by 
heating on a hot plate. Reactions were also monitored by using SHIMADZU LCMS-2020 
with solvents: A: 0.1% formic acid in water, B: acetonitrile. And reactions were also 
monitored by SHIMADZU prominence HPLC using Phenomenex Kinetex 1.7 XB-C18 
100A column (150 x 2.10 mm) and monitoring at 220, 254 nm with solvents: A: 0.05 M 
ammonium bicarbonate in water, B: acetonitrile. Flash chromatography was performed 
with Whatman silica gel (Purasil 60 Å, 230-400 Mesh). Proton magnetic resonance (
1
H-
NMR) spectral data were recorded on 400, and 500 MHz instruments. Carbon magnetic 
resonance (
13
C-NMR) spectral data were recorded on 100 and 125 MHz instruments. 
Phosphorus magnetic resonance (
31
P-NMR) spectral data were recorded on 162 MHz 
instruments. For all NMR spectra, chemical shifts (δH, δC) were quoted in parts per 
million (ppm), and J values were quoted in Hz. 
1
H and 
13
C NMR spectra were calibrated 
with residual undeuterated solvent (CDCl3: δH =7.26 ppm, δC =77.16ppm; CD3CN: 
δH=1.94ppm, δC =1.32ppm; CD3OD: δH =3.31ppm, δC =49.00 ppm;  DMSO-d6: 
δH=2.50ppm, δC =39.5ppm; D2O: δH=4.79 ppm) as an internal reference.  The following 
abbreviations were used to designate the multiplicities: s=singlet, d=doublet, dd=double 
doublets, t=triplet, q=quartet, quin=quintet, hept=heptet, m=multiplet, br=broad. Infrared 
(IR) spectra were recorded on a Perkin-Elmer FT1600 spectrometer. 
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OH
1) PCC, DCM
2) NaBH4, MeOH
OH
S1  
To a suspended solution of PCC (0.33 g, 1.5 mmol) in DCM (30 mL) was added farnesol 
(0.25 mL, 1.0 mmol). After being stirred for 1 h at rt, the reaction was diluted with ether 
(30 mL) and filtered through silica gel, and the filtrate was concentrated. To a solution of 
the residue in MeOH (10 mL) was added NaBH4 (0.08 g, 2.0 mmol) at 0 
o
C. After being 
stirred for 30 min, the reaction was quenched with sat. aq. NH4Cl solution, and MeOH 
was removed under reduced pressure. The aqueous layer was extracted with hexanes and 
the combined organic layer was dried over anhydrous Na2SO4. Concentration under 
reduced pressure followed by purification by silica gel column chromatography 
(hexanes/ethyl acetate = 95/5) afforded S1 (0.16 g, 36%). 
1
H NMR (400 MHz, 
Chloroform-d) δ 5.44 (td, J = 7.1, 1.7 Hz, 1H), 5.14 – 5.06 (m, 2H), 4.10 (dd, J = 7.2, 1.0 
Hz, 2H), 2.15 – 1.95 (m, 8H), 1.75 (s, 3H), 1.68 (s, 3H), 1.60 (s, 6H); LRMS (EI) calcd 
for C15H27O ([M + H]
+
): 223.21, found: 223.18. 
 
 
 
(NH3)OH OPO(OH)2
H3PO4, pyridine
Et3N, Ac2O
12S1  
To a solution of phosphoric acid (7.0 mg, 0.072 mmol), pyridine (29 L, 0.36 mmol), and 
S1 (80 mg, 0.36 mmol) was added Et3N (20 L, 0.14 mmol). After being stirred for 30 
min, acetic anhydride (14 L, 0.14 mmol) was added to the reaction mixture. The 
reaction mixture was stirred at 80 
o
C for 24 h, and the reaction was cooled to room 
temperature. The reaction was quenched with water (1 ml) and stirred for 1 h at 80 
o
C. 
The reaction mixture was cooled to room temperature, and the aqueous phase was 
extracted with ether (1 ml x 3). Lyophilization of the aqueous phase gave the crude 
product. Purification by DOWEX 50WX8 afforded (2Z,6E)-farnesyl phosphate 12 (21 
mg, 73%) as a white solid. 
1H NMR (400 MHz, Deuterium Oxide) δ 5.40 (t, J = 7.3 Hz, 
1H), 5.20 – 5.12 (m, 2H), 4.35 (t, J = 7.0 Hz, 2H), 2.15 – 2.00 (m, 8H), 1.73 (s, 3H), 1.66 
(s, 3H), 1.59 (s, 6H); LRMS (EI) calcd for C15H28O4P ([M + H]
+
): 303.17, found: 303.19. 
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S2  
To a solution of 6-amino-1-hexanol (19 mg, 0.16 mmol) and dansyl chloride (36 mg, 0.13 
mmol) in DCM/DMF (4 : 1, 1.0 mL) was added Et3N (28 L, 0.20 mmol). After being 
stirred for 7 h at rt, the reaction was quenched with sat. aq. NaHCO3 solution. The 
aqueous layer was extracted with AcOEt and the combined organic layer was dried over 
Na2SO4. Concentration under reduced pressure followed by purification by silica gel 
column chromatography (AcOEt) afforded S2 (44 mg, 94%). 
1
H NMR (400 MHz, 
Chloroform-d) δ 8.59 (brs, 1H), 8.32 (d, J = 8.6 Hz, 1H), 8.26 (dd, J = 7.3, 1.3 Hz, 1H), 
 
S4 
 
7.61 – 7.51 (m, 2H), 7.23 (d, J = 7.4 Hz, 1H), 4.63 (t, J = 6.2 Hz, 1H), 3.50 (t, J = 6.6 Hz, 
2H), 2.93 (s, 6H), 2.95 – 2.85 (m, 2H), 1.40 – 1.32 (m, 4H), 1.15 (h, J = 3.9, 2.9 Hz, 4H); 
LRMS (EI) calcd for C18H27N2O3S ([M + H]
+
): 351.17, found: 351.21. 
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To a solution of S2 (20 mg, 0.057 mmol) and Et3N (16 L, 0.12 mmol) in MeCN (0.2 
mL) was added 4-nitrophenyl chloroformate (18 mg, 0.088 mmol). After being stirred for 
20 h at rt, the reaction was quenched with sat. aq. NaHCO3 solution. The aqueous layer 
was extracted with AcOEt and the combined organic layer was dried over Na2SO4. 
Concentration under reduced pressure followed by purification by silica gel column 
chromatography (hexanes/AcOEt = 8/2 – 6/4) afforded fluorescent linker 14 (28 mg, 
98%). 
1
H NMR (400 MHz, Chloroform-d) δ 8.61 (d, J = 8.5 Hz, 1H), 8.33 (d, J = 7.4 Hz, 
1H), 8.30-8.24 (m, 1H), 8.27 (d, J = 9.2 Hz, 2H), 7.57 (q, J = 7.9 Hz, 2H), 7.37 (d, J = 
9.2 Hz, 2H), 7.25 (brs, 1H), 4.74 (t, J = 6.2 Hz, 1H), 4.18 (t, J = 6.6 Hz, 2H), 2.95 (s, 6H), 
2.97 – 2.85 (m, 2H), 1.65 – 1.56 (m, 2H), 1.47 – 1.38 (m, 2H), 1.29 – 1.21 (m, 4H); 
LRMS (EI) calcd for C25H30N3O7S ([M + H]
+
): 516.18, found: 516.26. 
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4  
To a solution of park’s nucleotide (2.6 mg, 2.2 mol) and Hünig’s base (1.6 L, 8.9 
mol) in Acetone/H2O (3 : 1, 0.4 mL) was added 14 (2.3 mg, 4.5 mol). After being 
stirred for 3 h at rt, the reaction mixture was filtered and was concentrated under reduced 
pressure. The crude product was purified by reverse phase HPLC [column: HYPERSIL 
GOLD™ (175 Å, 12 m, 250 x 10 mm), solvents: a gradient elution of 0 : 100 to 30 : 70 
CH3CN : 0.05 M aq. NH4HCO3 over 30 min, flow rate: 2.0 mL/min, UV: 254nm] to 
afford park’s nucleotide-N-C6-dansyl (4) (3.3 mg, 96%, the retention time: 22.7 min). 1H 
NMR (400 MHz, Deuterium Oxide) δ 8.46 (d, J = 8.6 Hz, 1H), 8.27 (d, J = 8.7 Hz, 1H), 
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8.23 (d, J = 7.3 Hz, 1H), 7.89 (d, J = 8.1 Hz, 1H), 7.66 (q, J = 7.4 Hz, 2H), 7.38 (d, J = 
7.6 Hz, 1H), 5.91 (d, J = 3.7 Hz, 1H), 5.89 (d, J = 7.9 Hz, 1H), 5.41 (dd, J = 7.3, 3.2 Hz, 
1H), 4.32 – 4.26 (m, 2H), 4.25 – 4.02 (m, 10H), 3.90 (dt, J = 9.7, 3.0 Hz, 1H), 3.82 – 3.70 
(m, 3H), 3.66 – 3.54 (m, 3H), 3.04 (t, J = 6.3 Hz, 2H), 2.92 (t, J = 6.5 Hz, 2H), 2.84 (s, 
6H), 2.26 – 2.19 (m, 2H), 2.13 – 2.02 (m, 1H), 1.95 (s, 3H), 1.87 – 1.78 (m, 1H), 1.74 – 
1.62 (m, 2H), 1.47 – 1.32 (m, 4H), 1.37 (d, J = 7.2 Hz, 3H), 1.34 (d, J = 6.7 Hz, 3H), 1.29 
(d, J = 7.7 Hz, 3H), 1.27 (d, J = 7.6 Hz, 3H), 1.13 – 1.06 (m, 2H), 1.04 – 0.97 (m, 2H), 
0.85 – 0.68 (m, 4H); LRMS (EI) calcd for C59H90N11O30P2S ([M + H]
+
): 1526.51, found: 
1526.40. 
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The kinetic parameter evaluation via MraY activity assay. (A)The correlation between 
the concentration of substrate (farnesyl phosphate; x axis) and rate (V; y axis). (B) The 
correlation between the concentration of substrate (neryl phosphate; x axis) and rate (V; y 
axis). The kinetic assays were carried out at room temperature in 50mM Tris-HCl pH 8.0, 
Triton X-100 (0.5%, 11.25 L), 0.5 M MgCl2 (10 L), 2 M KCl (10 L), 2 mM park’s 
nucleotide-N

-C6-dansyl (3.75 L), 20 mM farnesyl phosphate or 10 mM neryl 
phosphate. To a stirred reaction mixture, 1 mg/L P-60 membrane fractions (15 L) was 
added (total volume of reaction mixture: 100 L). The reaction mixture was quenched 
with CHCl3 (200 L). Two phases were mixed via vortex and centrifuged at 25,000g for 
10 min. The upper aqueous phase was assayed via reverse-phase HPLC. The water phase 
(10 L) was injected into HPLC (column: Kinetex 5u C8 100Å, 150x4.60 mm; solvent:  
acetonitrile : 0.05 M aq. NH4HCO3 = 25 : 75; UV: 350 nm; flow rate: 0.5 mL/min) and 
the area of the peak for lipid I derivative was quantified. The figures and kinetic 
parameters values (KM and Vmax) were obtained by nonlinear regression analysis using 
the Michaelis–Menten equation with the GraphPad Prism program(GraphPad Software, 
San Diego, CA). 
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Purification of HyMraY 
MraY was cloned from Hydrogenivirga spp. into a pBAD (Invitrogen, Carlsbad, CA) 
derived vector. Expression was performed in the Lemo21(DE3) strain (NEB, Ipswich, 
MA). Cells were lysed and the membrane fraction was solubilized in decyl-maltoside 
(Anatrace, Maumee, OH). The protein was purified by affinity chromatography using an 
N-terminal His-tag followed by size-exclusion chromatography. 
